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Abstract  The high-throughput data generated by microarray experiments provides complete set of genes being expressed 
in a given cell or in an organism under particular conditions. The analysis of these enormous data has opened a new 
dimension for the researchers. In this paper we describe a novel algorithm to microarray data analysis focusing on the 
identification of genes that are differentially expressed in particular internal or external conditions and which could be 
potential drug targets. The algorithm uses the time-series gene expression data as an input and recognizes genes which are 
expressed differentially. This algorithm implements standard statistics-based gene functional investigations, such as the log 
transformation, mean, log-sigmoid function, coefficient of variations, etc. It does not use clustering analysis. The proposed 
algorithm has been implemented in Perl. The time-series gene expression data on yeast Saccharomyces cerevisiae from the 
Stanford Microarray Database (SMD) consisting of 6154 genes have been taken for the validation of the algorithm. The 
developed method extracted 48 genes out of total 6154 genes. These genes are mostly responsible for the yeast’s resistants at 
a high temperature. 
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1. Introduction 
Microarray technology enables to measure the expression 
level of all or most of the genes in the genome 
simultaneously. The global scale gene expression profiling 
has revolutionized medical research allowing search for 
disease-related genes in a systematic and unbiased 
manner[1]. 
The identification of new genes from microarray data 
within a particular tissue type provide more reliable 
reference than are conventionally used techniques [2, 3-5]. 
Microarray data can be stratified on the basis of fold changes 
in expression [3], variance of expression [2, 5] or integrative 
correlations [4]. Candidate genes can be further selected 
from stratified data and frequently indicate expression 
stabilities [2-4]. However, the main requirement to the 
microarray data is an identification of new reference genes 
which demonstrate consistent stability across multiple tissue 
or cell types, and/or disease states [6]. 
As microarrays technologies have become more prevalent, 
the challenges associated with collection, management, and 
analysis of data from each experiment have essentially 
increased. Robust laboratory protocols improved 
understanding of the complex experimental design and 
decreased prices for some commercial platforms. These 
trends drive the field to more sophisticated experiments 
generating huge amounts of data [7]. With the help of these 
new technologies, we can find out answer of some 
challenging questions like (i) what are the functional roles of 
different genes and in what cellular processes do they 
participate?  (ii) how are genes regulated, how do genes and 
gene products interact, what are these interaction networks? 
(iii) how does gene expression level differ in various cell 
types and states, how is gene expression changed by various 
diseases and treatment? 
In detail, the hybridized RNA is excited by a laser in 
microarray. The spot will be red, if the RNA from the sample 
population is in abundance. If the RNA from the control 
population is in abundance, it will be green. If sample and 
control bind equally, the spot will be appear yellow, while if 
neither binds, it will appear as black. Hence, from the 
fluorescence intensities and colors for each spot, the relative 
expression levels of the genes in the sample and control 
populations can be measured.  
By measuring transcription levels of genes in an organism 
under different biological conditions, such as various 
developmental stages and diverse states, we can develop 
gene expression profiles that distinguish the dynamic 
functioning of each gene in the genome. The gene expression 
data are represented in the form of a table with rows 
indicating genes, columns representing samples (e.g. various 
developmental stages, tissues and diverse drug treatments). 
Each element of the matrix corresponds a number 
representing the expression level of the particular gene in the 
particular sample. We generally call such table as the gene 
expression matrix. For instance, if an over expression of 
certain genes is correlated with a certain disease, we can fix 
 
 
which conditions affect the expression of these genes and 
which other genes have similar expression profiles. Hence, 
we can investigate which compounds (potential drugs) lower 
the expression level of these genes [8]. 
DNA microarray array technology were used to 
investigate the functions of genes and also to the diagnosis of 
diseases [11]. With the help of microarray data analysis it 
was possible to discover drug targets [12]. In the recent times 
several methods have been developed for the analysis of 
gene expression data [13, 14]. Among these techniques, the 
clustering is most commonly used data analysis methods. 
Clustering generally groups the gene expression data with 
similar expression pattern, i.e. co-expressed genes. Due to 
various drawbacks of clustering techniques applied to gene 
expression analysis[15], we have proposed a novel algorithm 
which uses standard statistical functions, instead of 
clustering, for the analysis of differentially expressed genes. 
Our algorithm is also able to handle noises in the data, 
redundancy/replicate handling and testing the significance of 
data before analysing it. Finally, our algorithm extracts a list 
of genes which are differentially expressed in the dataset 
which can be used as the best drug target. 
2. Proposed Algorithm 
Our algorithm includes seven steps processing of data. At 
each step we eliminate some none useful gene or make the 
data more robust and systematic to help further processing of 
data. In this approach we have used very simple statistical 
technique to achieve the goal. These steps are:  
Step 1. Ratio and logarithmic conversion of microarray 
data. When the raw fluorescence intensity (red) cy5 is 
plotted against cy3 (green) most of the data are clustered near 
the bottom left of the plot showing an asymmetric 
distribution of the raw data. This is thought to be result of 
imbalance of red and green intensities during plot sampling 
resulting in ineffective discrimination of differentially 
ex-pressed gene. For example, a gene that is up-regulated by 
a factor of 4 has an expression ratio of 4 (R/G = 4G/G = 4). 
However, for the case where gene is down-regulated by a 
factor of 4, the expression ratio becomes 0.25 (R/G = R/4R = 
¼). Thus up-regulation is blown up and mapped between 1 
and infinity, whereas down-regulation is compressed and 
mapped between 0 and 1. 
   ,1mappedonupregulati  
 1,0 mappedtiondownregula  
One way we use to improve data discrimination is to 
transform cy5  cy3 value by taking the logarithm of base 2. 
The transformation produces more uniform distribution of 
data and has advantage to display up-regulated and 
down-regulated gene more symmetrically and more 
com-parable. To further normalize the data we put the data 
point horizontally by plotting the log ratio of cy5/cy3 against 
the average log intensities. In the representation the data are 
roughly symmetrically distributed around the horizontal axis. 
The differentially expressed gene then be more easily 
visualized. This form of representation is called ‘intensity 
ratio plot’. The linear regression is used in all these instances. 
A non-linear regression may produce a better fitting and help 
to eliminate the bias for data which not confirm to linear 
relationship owing to systematic sampling error. The most 
frequently used regression type is known as LOWESS 
(locally weighted scatter plot smoother) regression[9]. 
Step 2. Elimination of gene that fail to provide data in 
majority of experiment. In this step we remove that rows 
corresponding to gene that were not expressed or majority 
not expressed on any chip. In many of the cases due to some 
experimental problem some genes expression cannot be 
measured on the gene chip due to (i) wrong probing of gene 
on microarray chip, (ii) some specialized gene which are 
expressed in only a specific cell or specific condition are thus 
not expressed in that cell we are working on, (iii) scanner 
have some problem in that region to read the fluorescence 
value of gene, and (iv) due to defects in machine which make 
that microarray chip for Robotic probing. It is not hard and 
fast rule that if data is missing then we have to eliminate the 
row containing that gene. It can be a genuine problem that 
particular gene is actually not expressed in that particular 
condition.  
In this algorithm we have considered that if missing values 
for a particular row are less than or equal to 40 % then 
missing values will be filled up by a zero value, indicating 
that genes are not expressed. If missing values in a row are 
more than 40 % then that particular row will be removed 
from the main dataset and will not be used further for 
analysis. 
Step 3. Analysis of significance of data. In this step we 
check significance of data. The t-statistics is based on the 
assumption that the variability in these measurements 
follows a normal distribution, which means there is some 
pattern that is present in data which can be analyzed and may 
be interpreted as a result. Those data which are highly 
random and does not have any significance cannot be 
proceed for further analysis. 
Step 4. Replicate handling. In replicate handling we 
remove those genes whose expression level are taken or 
noted more than one time in gene expression data. Thus, each 
gene should have only one entry. This will remove the 
redundancy in dataset. The multiple entry may produce due 
to presence of more than one position of single probe or 
different gene coding for same protein having different 
position or due to manual or machine error in detecting and 
noting expression level of gene. These redundancies will 
increase the volume of data as well as analysis time. This 
step is optional if we are sure that our data is quite mature 
and it does not have redundancy. 
Step 5. Elimination of gene having less than two-fold 
change in expression level. We eliminated those genes that 
do not show considerable variation in expression level. In the 
dataset, positive value means up-regulation of expression in 
cy5 labeled gene and negative value means down-regulation 
of cy5 labeled gene. Those genes which neither show 
 
 
up-regulation nor down-regulation at least of half of its 
normal condition or which have less variation in expression 
level in control and diseased condition are not useful [10]. 
Thus, we have filtered the data and taken only those genes 
which show variation in expression level more than half of 
its expression level in control condition. For this, we have 
taken mean of each row and extracted only those rows or 
gene which have 1≤mean<−1, that actually represent change 
in expression level of at least half of its normal condition. 
Step 6. Conversion of datasets using logsigmoid 
function. At this step we have used log-sigmoid function to 
transform values in the range [0, 1] to make data more 
convergent which help us for further analysis. This 
conversion function is also useful as it transform all the 
negative values in positive range which is very useful for 
statistical data analysis. The log-sigmoid transformation 
takes the input, which can have any value between [+∞ to −∞] 
and squashes the output into the range [0, 1]. The transfer 
function is given by, 
xe
xsigmoid


1
1)(log
 
 Step 7. Elimination of genes that have high variation 
across the collection of sample. At this step we remove 
those genes which do not have consistent variation or 
variance in expression level in all different experimental 
condition in different time series. In this algorithm, we have 
eliminated those genes which have more than 36 % of 
variation because we are interested in those genes which 
show consistent differential expression level in disease case. 
Thus, we can use that gene or gene product for drug target to 
inhibit the symptom of that particular disease case. 
Suppose we have n number of genes at m different time 
points, expression level of gene n will be 
nmnnn xxxx ,....,,, 321, . We have calculated the coefficient of 
variance (CV) for each row in the dataset. The CV is given 
by, 
100.. 
x
SDVC
 
where SD and x  are standard deviation and mean 
respectively. By using coefficient of variance those genes 
which show less than 36 % variation are selected as they 
show consistency and other that show more than 36 % 
variation are deleted out because they are not representing as 
marker gene of that state. This cut off can be changed 
according to our need, bigger the cut off bigger will be the 
output. The flow chart of the proposed algorithm is presented 
in Figure 1. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.  Flow chart of the proposed algorithm 
 
 
3. Evaluation of the Algorithm 
The proposed algorithm has been implemented in Perl 
programming language. We have tested the proposed 
algorithm on time-series gene expression data of 
Saccharomyces cerevisiae (yeast) consisting of 6,154 genes 
and found that our algorithm extracts only 48 genes, i.e. 
0.78 % of total number of genes. Thus, the proposed 
algorithm is highly efficient as it extract only a small number 
of genes as the candidate genes from whole dataset. Its 
performance in respect of time and space complexity is 
moderately well. The asymptotic time complexity of the 
algorithm is the quadratic time O(n2). The main beauty of the 
proposed algorithm is that it is quite simple which can be 
easily implemented by anyone using almost any 
programming language. As we know there is no consistent 
data format in microarray technology, so we can easily adjust 
the algorithm parameters to make it work for almost any file 
format. The other main feature of our algorithm is no use of 
clustering approach. Clustering approach suffers from (i) the 
problem of subjective nature of deciding which external 
criteria to use in the absence of formal statistical tests, to 
choose the number of clusters, (ii) it is also guaranteed to 
produce clusters from any data and there is currently no 
generally accepted way to test a null hypothesis of no 
clusters (e.g., data are distributed uniformly). For these 
reason, caution is required in interpreting the results of a 
cluster analysis method. The results always need to be 
examined to see if it is plausible that they are indeed natural 
clusters and not just artifacts of the algorithm[15]. 
4. Results and Discussions 
We have tested the proposed algorithm on the time-series 
gene expression data of Saccharomyces cerevisiae from 
Stanford Microarray Database (SMD) consisting of 6,154 
genes[16]. The program filtered 48 genes out of 6154. These 
are those genes which are majorly responsible for making 
yeast cell more resistant and tolerable at high temperature. 
Filtered genes with their coefficient of variance (CV) are 
given in Table 1. After analyzing the result it is found that 
out of 48 extracted genes, 32 genes are directly responsible 
for providing resistance tolerance for high temperature. In 
other view, if we suppress some selected gene from them and 
make the cell more susceptible for heat, then a small raise in 
temperature can kill the cell. Thus, these genes can act as 
best candidate for drug target in Saccharomyces species. 
Table 1.  A list of filtered genes with their CV values 
Extracted Genes C.V. Extracted Genes C.V. 
YAL060W 35.73 YIL136W 35.62 
YBR001C 35.84 YKL103C 35.89 
YBR072W 35.80 YLL026W 35.40 
YBR169C 35.58 YLL039C 35.89 
YCL042W 35.87 YLR178C 35.51 
YDL021W 35.89 YLR216C 35.58 
YDL022W 35.68 YLR251W 35.98 
YDL023C 35.80 YLR258W 35.96 
YDL124W 35.93 YLR259C 35.81 
YDR001C 35.95 YLR327C 35.45 
YDR074W 35.87 YML100W 35.37 
YDR171W 35.39 YML128C 35.59 
YDR214W 35.39 YMR105C 35.54 
YDR258C 35.37 YMR186W 35.74 
YER020W 35.90 YMR251W-A 35.88 
YER103W 35.88 YNL007C 35.97 
YFL014W 35.36 YNL015W 35.92 
YGL037C 35.64 YNL274C 35.92 
YGR142W 35.50 YOL117W 35.74 
YGR146C 35.56 YOR020C 35.57 
YGR248W 35.44 YOR027W 35.67 
YHL021C 35.83 YOR052C 35.77 
YHR104W 35.50 YOR230W 35.91 
YIL111W 35.62 YPL240C 35.75 
 
 
 
Figure 2.  Dot plot of C.V. values 
In addition, the result also provide that 8 genes (namely, 
YIL136W, YLR327C, YML128C, YMR251W-A, 
YOR052C, YCL042W, YDL023C and YHL021C) with 
unknown function that show more than two-fold change in 
expression level at high temperature. Thus, these can be 
better target or can be a novel field of research to find the 
function and participation of these genes in heat tolerance. 
Further, these 8 genes which are indirectly involved in heat 
tolerance like by harvesting energy, involving in cell 
signalling etc, whose role is not yet correlated with heat 
tolerance but it can be find out and this can also be a better 
drug target. A distribution of genes and their CV values (in %) 
are represented in the form of dot-plot in Figure 2. This 
figure has been plotted on the basis of intermediate results 
which have been obtained after the step 6 of the algorithm. 
At the step 6, we have got around 356 genes whose 
distributions are shown in the dot-plot. The thick-line in the 
Figure 2 indicates our threshold value (CV <= 36 %).  
5. Conclusions 
Microarray is a high throughput technique to analyze the 
gene expression of particular cell at the specific conditions. 
This high throughput data can further be utilized to identify 
the gene as a drug target. We proposed an anticlustering 
algorithm by using some standard statistical methods which 
is able to identify and filter genes as a drug target. Our 
algorithm allows to find a wide range of genes that 67 % of 
genes are directly involved in particular events. In addition, 
17 % genes having unknown function and 17 % genes are 
indirectly related with diseases are also identified. So this 
algorithm can be used to investigate genes for particular 
disease and it also opens a new dimension of research to find 
the function of genes whose functions are still unknown and 
to find the role of genes which are indirectly involved in 
disease state. The algorithm presented here is a fast and 
scalable for the identification and filtration of genes as a drug 
target. 
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